ID   RCNSi001-B
AC   CVCL_A1WR
SY   HU-DM2-A-2
DR   hPSCreg; RCNSi001-B
DR   Wikidata; Q105510737
RX   PubMed=33099106;
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of RCNSi002-A (Cellosaurus=CVCL_A1WS) and RCNSi002-B (Cellosaurus=CVCL_A1WT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33099106
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WQ ! RCNSi001-A
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33099106; DOI=10.1016/j.scr.2020.102051;
RA   Szabo E., Ree D., Jezso B., Vincze K., Foldes G., Molnar A.A.,
RA   Rethelyi J.M., Apati A.;
RT   "Generation of iPSC lines from peripheral blood mononuclear cells of
RT   identical twins both suffering from type 2 diabetes mellitus and one
RT   of them additionally diagnosed with atherosclerosis.";
RL   Stem Cell Res. 49:102051-102051(2020).
//